Today’s AI Top Pick: PEGA

8/3/2026 · Highly Shorted Deep Rotation RSI & Conf screen · a free sample of K3vl4r’s AI-curated picks.

AI-ranked from a screened shortlist, with entry strategy, targets, and risks.

Measured weekly model accuracy · PEGA62%21 resolved forecasts · 90d window · verify →

Today's pick · Highly Shorted Deep Rotation RSI & ConfPEGABUY NOW8.6 / 108/3/2026

PEGA is the cleanest 'don't chase' setup in the pool with all the fundamentals, forecast alignment, and a fresh positive catalyst. Multi-timeframe forecasts are uniformly constructive: 1h fc +14.49/+14.43/+23.76%, 4h +24.7/+48.17/+60.64%, 1d +35.75/+54.87/+33.39%, and 1wk mid/long +6.72/+46.44%. Bullish_prob is 1.0 with near_term_bullish 0.6 — solid conviction without the euphoric single-bar reading. Critically, PEGA is NOT at the top of any range: 1h pos-in-range 24.42%, 4h 62.49%, 1d 70.58%, 1wk 24.25%, with a -29.12% weekly drawdown from the 21-bar high. Compare that to EPAM (RSI 67.95, at 100% on 1h/4h/1d — textbook chase), TMDX (100%/95%/89% across intraday TFs), or UPWK (100% on 1h/4h). PEGA gives you upside participation without paying the local high — the definition of a favorable entry. Fundamentals are best-in-class among the top-scored names: PE 17.26, fwdPe 11.56, PEG 1.14, ROE 54.69%, profitMargin 18.66%, debtEq just 0.13, and targetUpsidePct +42%. This isn't a hope-and-pray small cap — it's a $5B software business with real cash generation, and it just announced a special cash dividend (7/31) which is a hard positive catalyst, plus investor conference appearances. The 17.79% short float on a name that is genuinely improving fundamentally is squeeze fuel. Why today vs. waiting: the setup already has a -29% weekly pullback baked in and price is sitting in the lower quarter of hourly/weekly ranges. Waiting for a deeper dip risks missing the mid-timeframe forecast (+48% 4h mid, +55% 1d mid). This is the pullback other names still need.

Entry zone

$30.40–$31.20 (current $30.88, add on any dip toward the 1h/1wk low quartile)

Stop loss

$28.20 (below the recent weekly pivot; ~-8.7% risk, invalidates the pullback thesis)

First target

$36.00 (aligns with 1d fc_mid +54% path and prior resistance)

Longer target

$43.85 (analyst target upside +42%, matches 1wk fc_long +46%)

Risks

Short float 17.79% cuts both ways — a broader tech pullback can force violent margin liquidation before the squeeze thesis plays out
1wk fc_short is -5.33%, meaning near-term weekly forecast is still slightly negative before mid/long kicks in
Sales growth is only +3.6% YoY — this is a re-rating trade, not a growth blowout; miss on Q2 could deflate the multiple
PE 17 / fwdPe 11.56 is reasonable but not deep-value; a broader software de-rating (see NCNO, MNDY selling off) could drag PEGA with it
Special dividend already announced — the catalyst pop may partially be priced into the recent bounce

Honorable mentions

UPWKBest pure fundamentals in the pool (fwdPe 5.26, PEG 0.4, profitMargin 13.81%, ROE 18.76%) with strong multi-TF forecasts (4h long +64%, 1d mid/long +54%). Only knock: 1h/4h sitting at 100% of range, so entry is slightly chasey vs PEGA. Positive 'AI spending narrative' headline supports the thesis.

TMDXHighest composite score (14.25), best fundamentals-adjusted growth story (salesYoY +30%, profitMargin 27%, ROE 45%, targetUpside +43%). Forecast tape is exceptional (4h long +68.7%, 1d mid +57%). Held back to #3 only because 1h/4h/1d all sitting at 89–100% of range — better to buy the first pullback than the breakout day.

Full ranking (30)

#	Symbol	Verdict	Score	Read
1	PEGA	BUY NOW	8.6	Multi-TF forecasts all positive, sitting in lower quartile of hourly/weekly range, special dividend catalyst, fwdPe 11.56 with 54% ROE.
2	UPWK	BUY NOW	8.3	Cheapest fundamentals in pool (fwdPe 5.26, PEG 0.4) with 4h/1d forecasts +54-64% — slightly extended intraday but thesis intact.
3	TMDX	BUY PULLBACK	8.0	Elite fundamentals (30% sales growth, 45% ROE) and huge forecasts but extended at 89-100% of intraday ranges — wait for -3-5% dip.
4	MNDY	BUY PULLBACK	7.4	1wk fc_long +136%, 1d fc_long +54%, but 1h/4h forecasts negative and layoff headline is a caution flag.
5	KVYO	BUY NOW	7.2	Clean multi-TF pattern with near_term_bullish 1.0, Citi PT raise to $34, targetUpside +62%, not stretched in ranges.
6	EPAM	BUY PULLBACK	7.1	Massive forecasts (1wk long +68%, 1d long +54%) and cheap fwdPe 7.44, but RSI 67.95 and 100% range positioning across 1h/4h/1d screams chase.
7	IT	BUY PULLBACK	7.0	Gartner: 1wk fc mid/long +73%/+135%, ROE 95%, but earnings 8/3 event risk and targetUpside only +6%.
8	OWL	BUY PULLBACK	6.8	1d fc_long +35% and clean bullish weekly, but 1h/4h short forecasts negative — wait for intraday flush.
9	NCNO	BUY PULLBACK	6.7	All TFs at 100% range with only modest forecasts (+10-30%); PE 152 keeps this from being a table-pounder.
10	INSP	BUY PULLBACK	6.6	Absurd 1wk forecast (+70/+183/+269%) and near_term_bullish 1.0, but UBS just assumed Sell with $39 PT — landmine risk.
11	FOUR	BUY PULLBACK	6.2	1wk long +39.5% and PEG 0.52, but 1h forecast negative (-16%) and at top of 1h/4h/1wk range — needs cooldown.
12	PTLO	WAIT	5.9	1wk fc_mid +117% is intriguing but 1wk fc_long is -5.8% and daily/hourly forecasts thin — earnings volatility risk.
13	VSTM	BUY PULLBACK	5.5	Positive Phase 2 dosing catalysts and 158% target upside, but -391% profit margin makes this speculative biotech only.
14	CNXC	WAIT	5.4	Solid 1d forecasts (+13/+52/+52%) but recent -20% weekly damage and 'obliterated' headline says wait for stabilization.
15	DXC	WAIT	5.3	1wk fc_long +72% and near_term_bullish 1.0, but 1h fc -40% and targetUpside is -2.8% — analysts don't like it.
16	POST	WAIT	5.2	Undervalued narrative and stable fundamentals but expected_return only +7.9% — opportunity cost is high.
17	ARDT	WAIT	5.0	Bullish_prob only 0, 1h/4h forecasts negative, despite reasonable fundamentals.
18	QDEL	WAIT	4.9	1h dd -8.36% and 1h fc -23%; StockStory publishing '3 reasons to sell' is a headwind.
19	KD	WAIT	4.8	1d forecasts strong (+63%) but 1h/1wk forecasts deeply negative and analyst recom 3.33 with targetUpside 0.4% is a red flag.
20	VRDN	WAIT	4.8	Bullish weekly dd -30% and 90% target upside, but 1h dd -7.5% shows current weakness; biotech binary risk.
21	TTEC	AVOID	4.6	$121M microcap with 27.8% short float and debtEq 11.65; 1wk fc_short -29% is a warning.
22	TTAN	AVOID	4.5	All timeframe forecasts negative on the short/mid horizon; ServiceTitan re-rating hasn't started.
23	PGY	AVOID	4.2	Every single forecast horizon is negative post-earnings; the price target raises are lagging the tape.
24	CXT	AVOID	4.1	All short-term forecasts deeply negative (-19 to -25%) and bullish_prob 0 — screen match is stale.
25	LEU	AVOID	4.0	'Fully priced after 7x run' consensus and EPS estimate cuts; forecast profile mediocre.
26	DUOL	AVOID	3.9	TargetUpside is -14.9%, 1h/4h forecasts negative, at top of weekly range — recipe for disappointment.
27	VIA	AVOID	3.5	All forecast horizons deeply negative (1h/4h/1d shorts -29 to -35%); recent IPO with no earnings history.
28	ASAN	AVOID	3.4	39.5% short float looks juicy but -87% ROE, -20% profit margin — squeeze is the only thesis.
29	KLAR	AVOID	3.2	All forecasts negative, no fundamentals support, headlines are about Apple partnership not KLAR itself.
30	DLO	AVOID	2.8	Every forecast negative across all timeframes; screen passed on backward-looking metrics only.

Get AI top picks & forecasts on any stock

K3vl4r screens the market daily and ranks the best setups with AI — forecasts, scored fundamentals & technicals, and multi-horizon price targets. Create a free account to explore them all.

Create your free account →

Already a member? Sign in · Join our Discord